KennethB.GordonMD

Professor and Chair, Department of Dermatology Medical College of Wisconsin

Dr. Gordon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
10000 W Bluemound Rd
Wauwatosa, WI 53226
Phone+1 414-454-8000

Fax+1 414-805-3888

McGaw Medical Center of Northwestern UniversityResidency, Dermatology, 1993 - 1996
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1990 - 1993
Columbia University Vagelos College of Physicians and SurgeonsClass of 1990

PubMed

306 citations
Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up.
Kim A. Papp, Christopher E.M. Griffiths, Kenneth B. Gordon, Mark Lebwohl, Philippe Szapary
The British Journal of Dermatology. 2013-04-01
499 citations
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics.
Alan Menter, Bruce Strober, Daniel H. Kaplan, Dario Kivelevitch, Elizabeth Farley Prater
Journal of the American Academy of Dermatology. 2019-04-01
21 citations
Characterization of Patients with Psoriasis in Challenging-to-Treat Body Areas in the Corrona Psoriasis Registry.
Kristina Callis Duffin, Marc A Mason, Kenneth B. Gordon, Ryan W. Harrison, Margaux M. Crabtree
Dermatology. 2021-01-01

Bimzelx Shows Consistent Safety Profile Compared with Similar Psoriasis TreatmentsJune 14th, 2022
Risankizumab Shown to Be Safe over the Long TermMarch 18th, 2022